CRD-799

N/A

Report date: 2025/04/25 11:05:21

NME

Base Information

Drug NameCRD-799

Drug Alias NameCRD-799

ClassificationSmall molecules

Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 inhibitorsEukaryotic Translation Initiation Factor 2 Alpha Kinase 3 inhibitors

TargetsEukaryotic translation initiation factor 2-alpha kinase 4Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNagoya City University Chordia Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesChordia Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A